1. A. T. B. Moir, G. W. Ashcroft, T. B. B. Crawford, D. Eccleston, and H. C. Guldberg, Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain, Brain 93: 357 (1970).
2. E. Garelis, S. N. Young, S. Lal and T. L. Sourkes, Monoamine metabolites in lumbar CSF: The question of their origin in relation to clinical studies, Brain Res. 79: 1 (1974).
3. R. M. Post and F. K. Goodwin, Approaches to brain amines in Psychiatric patients: A reevaluation of cerebrospinal fluid studies, in “Handbook of Psychopharmacology”, Vol. 13, L. L. Iversen, S. D. Iversen, S. H. Snyder, eds., Springer Science+Business Media New York (1978).
4. R. M. Post and F. K. Goodwin, Approaches to brain amines in Psychiatric patients: A reevaluation of cerebrospinal fluid studies, in “Handbook of Psychopharmacology”, Vol. 13, L. L. Iversen, S. D. Iversen, S. H. Snyder, eds., Springer Science+Business Media New York (1978).
5. M. Bulat and B. Zivcovia, Origin of 5-hydroxylindoleacetic acid in the spinal fluid, Science 173: 738 (1971).